Showing results (101-110 of 141) with videos related to
Sort By:
Pageof 15
Healthcare Quarterly (Toronto, Ont.)|July 3, 2004
Bill 8--accountability and controlSimon Chester, Maureen Quigley, Graham ScottNursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 23, 2016
Growing evidence of cuts in services and nursing postsKale Williams, Graham Scott, Daniel AllenF1000Research|April 30, 2016
Innovations and best practice in undergraduate educationGeorge R Littlejohn, Graham Scott, Mary WilliamsJournal of Clinical Pharmacology|November 12, 2013
A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazarFrances Stringer, Joost DeJongh, Graham Scott, et al.Journal of Medical Imaging and Radiation Oncology|August 6, 2014
Radiotherapy in the Barwon South Western Region: a rural perspectiveMargaret J Henry, Phil Jones, Kate Morrissy, et al.Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|April 28, 2007
Hallucinations in adolescents with post-traumatic stress disorder and psychotic disorderJames Graham Scott, Barry Nurcombe, Judith Sheridan, et al.Dermatology (Basel, Switzerland)|July 2, 2003
Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated, safe, and effective. An open studyDiamant Thaçi, Katrin Steinmeyer, Marie-Eve Ebelin, et al.European Journal of Clinical Pharmacology|September 11, 2012
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agentFrances Stringer, Graham Scott, Marian Valbuena, et al.Journal of Clinical Pharmacology|January 30, 2004
Lumiracoxib: pharmacokinetic and pharmacodynamic profile when coadministered with fluconazole in healthy subjectsGraham Scott, Linda Yih, Ching-Ming Yeh, et al.Clinical Pharmacokinetics|April 15, 2004
Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxibGraham Scott, Christine Vinluan Reynolds, Slavica Milosavljev, et al.Pageof 15